BlackRock’s MIRA Pharmaceuticals MIRA Stock Holding History

BlackRock’s Portfolio MIRA Stock Details MIRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$232K	Buy	244,622 +132,276	+118%	+$134K	﹤0.01%	4778
2026 Q1	$120K	Buy	112,346 +2,577	+2%	+$3.23K	﹤0.01%	4920
2025 Q4	$166K	Hold	109,769	–	–	﹤0.01%	4777
2025 Q3	$149K	Buy	+109,769	New	+$159K	﹤0.01%	4742

Other funds holding MIRA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CSI

Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

FAB

First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

BlackRock's MIRA Position: Q2 2026 in Review

BlackRock increased its MIRA Pharmaceuticals (MIRA) stake by 118% in Q2 2026, buying an estimated $134K and bringing the position to 244,622 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #4778.

BlackRock first reported a position in MIRA in Q3 2025 and has held it in 4 quarters since. 26 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.

BlackRock held 244,622 shares of MIRA Pharmaceuticals worth $232K as of Q2 2026.
BlackRock bought 132,276 MIRA Pharmaceuticals shares in Q2 2026, an estimated $134K.
MIRA Pharmaceuticals made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4778 holding.
BlackRock first reported a position in MIRA Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.